TripleBar Bio, Inc. — Form D
TripleBar Bio, Inc. of EMERYVILLE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-10-25. The offering totals $20.5M, of which $19.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-10-25
- Form: D
- Accession: 0001998555-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.5M
- Amount sold: $19.8M
- Remaining: $761K
- Investors: 9
- Date of first sale: 2023-10-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-495601
Issuer
- Name: TripleBar Bio, Inc.
- CIK: 0001998555
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 1250 45TH ST STE 315, EMERYVILLE, CA, 94608
- Phone: (617) 331-6411
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Maria Cho | Director | Emeryville, CA |
| David Friedberg | Director | San Francisco, CA |
| Howard Levin | Director | Minneapolis, MN |
| Rose Wardle | Director | Emeryville, CA |
| Maria Cho | Executive Officer | Emeryville, CA |
More